29. Redirected Allogeneic T Cells for Adoptive Cell Therapy of Cancer

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)36601-1
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

T-Cell Depleted Allogeneic Hematopoietic Cell Transplants as a Platform for Adoptive Therapy With Leukemia Selective or Virus-Specific T-Cells

Bone Marrow Transplantation
TransplantationHematology
2015English

Developing Allogeneic Double Negative T Cells as a Novel Off-The-Shelf Adoptive Cellular Therapy for Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Adoptive T-Cell Therapy for Solid Tumors

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2017English

Development of Chimeric Antigen Receptor-Redirected T Cell Therapy Targeting L1-Cam in Ovarian Cancer

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Adoptive Cell Therapy—Harnessing Antigen-Specific T Cells to Target Solid Tumours

Cancers
Cancer ResearchOncology
2020English

Multi-Cistronic Vector Encoding Optimized Safety Switch for Adoptive Therapy With T-Cell Receptor-Modified T Cells

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2013English

Adoptive Immunotherapy of Cancer Using CD4+ T Cells

Current Opinion in Immunology
AllergyImmunology
2009English

Adoptive T-Cell Therapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors

International Journal of Hematology
Hematology
2013English

T Cells Stimulated by CD40L Positive Leukemic Blasts-Pulsed Dendritic Cells Meet Optimal Functional Requirements for Adoptive T-Cell Therapy

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy